Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2012-12-19
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ATRIAL FLUTTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 32.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate BUNDLE BRANCH BLOCK RIGHT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 32.0); relationship: POSSIBLE
moderate
assessed
2026-08-18
Moderate VENTRICULAR SEPTAL DEFECT — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 32.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.